Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia in men aged 46 is not significantly linked to depression, anxiety, quality of life, self-esteem, or sexual symptoms.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Overweight women with PCOS are more likely to have excess male hormones.

A woman with a rare adrenal tumor and hormonal disorder had improved testosterone levels after surgery, but her menstrual irregularities continued.

Some men can have female pattern baldness without hormonal abnormalities or signs of feminization.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

Severe acne in a young girl may indicate underlying hormonal issues.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Emblica officinalis and Eclipta alba may help treat hair loss naturally.

Low ferritin and Vitamin D levels may cause hair loss after COVID-19.

PCOS is a complex condition that affects women's hormonal balance and metabolism, requiring lifestyle changes and medical management.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Patients with one autoimmune disease should be checked for other autoimmune disorders.

The conclusion is that adult males with muscle weakness and hormonal imbalances should be tested for Kennedy's disease.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Polycystic Ovary Syndrome (PCOS) often leads to severe acne, and lifestyle changes and hormonal treatments can help manage it.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

The document concludes that skin aging in women can be caused by UV exposure and hormonal changes, and treatments like hormone replacement therapy and various skin therapies can help.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.